MYL News and Press, Mylan N.V. From 09/20/20

The coronavirus vaccines are coming -- or at least the odds are looking better every day that they are. Investors who want to potentially benefit from the launches of coronavirus vaccines have plenty of options from which to choose. However, the number of low-risk leaders in the race are few. H...

The European Commission (EC) has signed off on the proposed combination of Mylan (NASDAQ: MYL ) and Pfizer's (NYSE: PFE ) Upjohn unit. More news on: Mylan N.V., Pfizer Inc., Healthcare stocks news, Merger & acquisition news, Read more ...

HERTFORDSHIRE, England and PITTSBURGH , Sept. 15, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that the Technical Board of Appeal of the European Patent Office (EPO) has held that Yeda Research and Development Company, Ltd.'s European Patent no. 2 949 335 related t...

HERTFORDSHIRE, England , PITTSBURGH and NEW YORK , Sept. 15, 2020 /PRNewswire/ -- Mylan  (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the European Commission (EC) for the proposed combination of Mylan and Pfize...

FDA approves Blueprint’s GAVRETO for lung cancer Blueprint Medicines Corporation ( BPMC ) announced that the FDA has given its approval to GAVRETO for treating adult patients with metastatic rearranged during transfection fusion-positive non-small cell lung cancer. Blueprint is coll...

HERTFORDSHIRE, England and PITTSBURGH , Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V.  (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury , together with President Rajiv Malik will present at the Morgan Stanley Virtual 18th Annual Glo...

HERTFORDSHIRE, England and PITTSBURGH , Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V.  (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury , together with President Rajiv Malik will present at the BofA Securities Virtual Global Healthc...

Nucleic acid vaccines, which are either DNA- or RNA-based, hold significant promise in the fight against COVID-19. Pharma giant Pfizer (NYSE: PFE) and clinical-stage Moderna (NASDAQ: MRNA) are the most prominent names involved in the development of messenger RNA (mRNA) coronavirus vaccin...

Mylan (NASDAQ: MYL ) has agreed to acquire Aspen Pharmacare Holdings Limited's thrombosis business in Europe for €641.9M to be paid in two tranches, €263.2M upfront and €378.7M on June 25, 2021. More news on: Mylan N.V., Healthcare stocks news, Merger & acquisi...

HERTFORDSHIRE, England , and PITTSBURGH , Sept. 8, 2020 /PRNewswire/ --  Mylan  N.V. (NASDAQ: MYL) today announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe ...